Recurrence Clinical Trials

98 recruitingLast updated: June 17, 2026

There are 98 actively recruiting recurrence clinical trials across 38 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1, Phase 4. Top locations include Beijing, Beijing Municipality, China, Nanjing, Jiangsu, China, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Recurrence Trials at a Glance

98 actively recruiting trials for recurrence are listed on ClinicalTrialsFinder across 6 cities in 38 countries. The largest study group is Not Applicable with 35 trials, with the heaviest enrollment activity in Beijing, Nanjing, and Barcelona. Lead sponsors running recurrence studies include Amsterdam UMC, location VUmc, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, and Chang Gung Memorial Hospital.

Browse recurrence trials by phase

Treatments under study

About Recurrence Clinical Trials

Looking for clinical trials for Recurrence? There are currently 23 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Recurrence trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Recurrence clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 98 trials

Recruiting
Phase 3

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Acute Myeloid LeukemiaRelapse/Recurrence
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS339 enrolled47 locationsNCT06713837
Recruiting
Phase 1

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

OsteosarcomaPulmonary Recurrence of Osteosarcoma
Emory University12 enrolled1 locationNCT06492954
Recruiting
Phase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Clostridioides Difficile Infection Recurrence
Bactolife A/S60 enrolled1 locationNCT07250724
Recruiting
Phase 2

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

RecurrenceRefractoryHigh Grade Glioma+4 more
Clinica Universidad de Navarra, Universidad de Navarra39 enrolled2 locationsNCT07424092
Recruiting

Cerebral Small Vessel Disease Progression Dependent on Stroke Type

StrokeBiomarkersStroke Recurrence+1 more
Johannes Dorst180 enrolled1 locationNCT07611136
Recruiting
Not Applicable

xDRIVE for Florida-based Cancer Patients

CancerLeukaemiaLymphoma+5 more
First Ascent Biomedical Inc.210 enrolled2 locationsNCT07167381
Recruiting

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Bladder (Urothelial, Transitional Cell) CancerBladder Cancer RecurrenceProgression of Bladder Cancer+2 more
Zhiping Wang150 enrolled1 locationNCT07589413
Recruiting
Not Applicable

Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

Circulating Tumor DNARecurrenceColon Cancer Stage II
UMC Utrecht1,320 enrolled29 locationsNCT06434896
Recruiting
Not Applicable

Opioid-free Anaesthesia in Breast Cancer Surgery

Breast CancerPain, ChronicPain, Postoperative+3 more
University of Ioannina200 enrolled1 locationNCT06404983
Recruiting
Phase 2

Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid LeukemiaRelapse/Recurrence
Shenzhen University General Hospital10 enrolled1 locationNCT07563179
Recruiting

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

CancerSurvivorshipRecurrent+2 more
Memorial Sloan Kettering Cancer Center1,000 enrolled4 locationsNCT07030686
Recruiting
Not Applicable

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

RecurrenceChronic Subdural Hematoma
Huashan Hospital830 enrolled1 locationNCT06401772
Recruiting
Phase 3

FMT Capsules for rCDI

FMTClostridioides Difficile Infection Recurrence
Helsinki University Central Hospital76 enrolled1 locationNCT07458984
Recruiting
Phase 2

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Neoplasm MetastasisEndometrial NeoplasmsNeoplasm Recurrence, Local
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06532539
Recruiting
Phase 2

Study of Lacutamab in Peripheral T-cell Lymphoma

Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Phase 2Phase 3

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Prostate CancerMetastatic Prostate CancerOligometastasis+3 more
VA Office of Research and Development464 enrolled20 locationsNCT04787744
Recruiting
Phase 2

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

HER2-negative Breast CancerHormone Receptor-Positive Breast CancerLocoregional Recurrence
Oana Danciu200 enrolled20 locationsNCT05467891
Recruiting

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Renal Cell Carcinoma (Kidney Cancer)Fear of Cancer Recurrence
Brigitta Rasmussen Villumsen105 enrolled3 locationsNCT07234656
Recruiting
Not Applicable

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

BRCA2 MutationFear of Cancer RecurrenceBreast Cancer Susceptibility Gene (BRCA1) Mutation
CHU de Quebec-Universite Laval250 enrolled1 locationNCT06817694